<논문>
1. Hea-Young Cho, Chong Ki Lee and Yong-Bok Lee, Preparation and Evaluation of PEGylated and Folate-PEGylated Liposomes Containing Paclitaxel for Lymphatic Delivery, J. Nanomater., 2016, 1-14 (2016)
2. Seo-Hee Heo, Dong-Seok Lee, Seong-Ho Ham, Jung-Hee Cho, Young-Dal Kwon, Yong-Bok Lee and Hea-Young Cho, Pharmacokinetic evaluation of paeoniflorin after oral administration of Paeoniae Radix extract powder to healthy Korean subjects using UPLC-MS/MS, J. Pharm. Invest., 46(3), 273-282 (2016)
3. Hea-Young Cho, Chong Ki Lee and Yong-Bok Lee, Preparation and Evaluation of PEGylated and Folate-PEGylated Liposomes Containing Paclitaxel for Lymphatic Delivery, J. Nanomater., 2015, 1-10 (2015)
4. Hea-Young Cho, Ji-Hoon Choi, In-Joon Oh and Yong-Bok Lee, Self-emulsifying drug delivery system for enhancing bioavailability and lymphatic delivery of tacrolimus, J. Nanosci. Nanotechnol., 15, 1831-1841 (2015)
5. Sook-Jin Kim, Sang-Hyuk Lee, Yong-Soo Kim, Hyo-Rin Jung and Hea-Young Cho, A rapid and selective LC-MS/MS method for the quantification of aripiprazole in beagle dog plasma and its application to a pharmacokinetic study. J. Pharm. Invest., 44(6), 465-472 (2014)
6. Hyo-Rin Jung, Sook-Jin Kim, Seong-Ho Ham, Jung-Hee Cho, Yong-Bok Lee and Hea-Young Cho, Simultaneous determination of puerarin and its active metabolite in human plasma by UPLC-MS/MS: Application to a pharmacokinetic study, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 971, 64-71 (2014)
7. Hea-Young Cho and Yong-Bok Lee, Nano-sized drug delivery systems for lymphatic delivery. Review, J. Nanosci. Nanotechnol., 14, 868-880 (2014)
8. Hea-Young Cho, Geun-Kyeong Park and Yong-Bok Lee, Simultaneous determination of morniflumate and its major active metabolite, niflumic acid, in human plasma by high-performance liquid chromatography in stability and pharmacokinetic studies, Biomed. Chromatogr., 27, 1438-1443 (2013)
9. Hea-Young Cho*, Hwa Yoon*, Hee-Doo Yoo, Se-Mi Kim and Lee YB, Influences of Organic Cation Transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects, AAPS Journal, 15, 571-580 (2013) (DOI : 10.1208/s12248-013-9460-z) *equal contributed author
10. Yoo HD*, Cho HY*, Lee SN, Yoon H and Lee YB, Population pharmacokinetic analysis of risperidone and 9-hydroxyrisperidone with genetic polymorphisms of CYP2D6 and ABCB1, J. Pharmacokinet. Pharmacodyn., 39, 329-341 (2012) *equal contributed author
11. Hee-Doo Yoo, Sang-No Lee, Hyun-Ah Kang, Hea-Young Cho, Il-Kwon Lee, and Yong-Bok Lee, Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D6*10/*10, Brit. J. Pharmacol., 164, 433-443 (2011)
12. Hee-Doo Yoo, Mi-Suk Kim, Hea-Young Cho and Yong-Bok Lee, Population pharmacokinetic analysis of glimepiride with CYP2C9 genetic polymorphism in healthy Korean subjects, Eur. J. Clin. Pharmacol., 67, 889-898 (2011)
13. Dong-Min Kim, Yoon Seong Kim, Hea-Young Cho, and Yong-Bok Lee, Scrub typhus meningoencephalitis occurring during doxycycline therapy for Orientia tsutsugamushi, Diagnostic Microbiology & Infectious Disease, 69, 271-274 (2011)
14. Eun Yong Chung, Hea-Young Cho, Ji-Hun Cha, Kyoung-Jin Kwon, Seol-Hee Jeon, Su Hyun Jo, Eun-Jung Kim, Hye Soo Kim and Hye Ju Chung, Inhibitory Effect of Nicardipine on hERG Channel, Biomolecules & Therapeutics, 18(4), 448-453 (2010)
15. H.Y. Cho, H.D. Yoo and Y.B. Lee, Influence of ABCB1 Genetic Polymorphisms on the Pharmacokinetics of Levosulpiride in Healthy Subjects, Neuroscience, 169, 378-387 (2010)
16. Kim MY, Seo EJ, Lee DH, Kim EJ, Kim HS, Cho HY, Chung EY, Lee SH, Baik EJ, Moon CH and Jung YS, Gadd45beta is a novel mediator of cardiomyocyte apoptosis induced by ischaemia/hypoxia, Cardiovasc. Res., 87(1), 119-126 (2010)
17. Hwa Yoon, Hea-Young Cho, and Yong-Bok Lee, Determination of ibudilast in human serum by high-performance liquid chromatography for pharmacokinetic study, Biomed. Chromatogr., 24(3), 324-328 (2010)
18. Sae-Byeok Shin, Hea-Young Cho, Dae-Duk Kim, Han-Gon Choi and Yong-Bok Lee, Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery, Eur. J. Pharm. Biopharm., 74(2), 164-171 (2010)
19. Hee-Doo Yoo, Hea-Young Cho and Yong-Bok Lee, Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1, British. J. Clin. Pharmacol., 69(1), 27-37 (2010)
20. Cho HY, Blum RA, Sunderland T, Cooper GJ, Jusko WJ, Pharmacokinetic and pharmacodynamic modeling of a copper-selective chelator (TETA) in healthy adults, J. Clin. Pharmacol., 49(8), 916-928 (2009)
21. H.Y. Cho, H. Yoon, Y.C. Lim and Y.B. Lee, Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects, Int. J. Clin. Pharmacol. Ther., 47(12), 770-779 (2009)
22. Cho WS, Cho M, Jeong J, Choi M, Cho HY, Han BS, Kim SH, Kim HO, Lim YT, Chung BH and Jeong J, Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles, Toxicol. Appl. Pharmacol.. 236(1), 16-24 (2009)
23. Hea-Young Cho, Hwa Yoon, Geun-Kyeong Park, and Yong-Bok Lee, Pharmacokinetics and Bioequivalence of Two Formulations of Rebamipide 100-mg Tablets; A Randomized, Single-Dose, Two-Period, Two-Sequence Crossover Study in Healthy Korean Male Volunteers, Clinical Therapeutics, 31(11), 2712-2721 (2009)
24. Hee-Doo Yoo, Sun-Ae Park, Hea-Young Cho and Yong-Bok Lee, Influence of CYP3A and CYP2C19 genetic polymorphisms on the pharmacokinetics of cilostazol in healthy subjects, Clin. Pharmacol. Ther., 86(3), 281-284 (2009)